International travel has gained significant momentum in the past decade and the trend is showing no signs of slowing down. As per the data released by the World Tourism Organization (UNWTO), an astounding 1.4 billion international tourist arrivals were recorded - a 6% rise from 2017. As per the observable trends, tourists are traveling in huge numbers to tropical and sub-tropical countries, including Thailand, Spain, and India. However, tourists are at a high risk of being exposed to diarrheal pathogens in these regions and thus, traveler’s diarrhea has emerged as one of the most common health problems faced by international travelers.
Traditionally, antibiotic prophylaxis is used to prevent traveler’s diarrhea, which is primarily caused by bacterial etiologies. The traveler’s diarrhea treatment market is expanding at a rapid pace, as awareness among travelers related to ill effects of traveler’s diarrhea is increasing. Furthermore, drug approvals by the FDA, rise in the number of research activities, and development of new therapeutics are some of the leading factors that are expected to drive the traveler’s diarrhea treatment market. The market for traveler’s diarrhea treatment is expected to reach a value of ~US$ 1.3 Bn by 2027.
Request a sample to get extensive insights into the Traveler’s Diarrhea Treatment Market
Antibiotics used to treat and manage traveler’s diarrhea have evolved at a rapid pace in the past 50 years due to a range of factors, including drug resistance, costs, and side-effects. However, with consistent developments in research, new and improved treatments for traveler’s diarrhea are entering the traveler’s diarrhea treatment market.
The Food and Drug Administration (FDA) has given approval to several new treatments and drugs in recent years. For instance, Aemcolo, an oral antibacterial rifamycin, was approved by the FDA in November 2018 to treat traveler’s diarrhea caused by E.coli. Clinical studies have revealed that rifamycin has greater efficiency in reducing the symptoms of diarrhea symptoms compared to placebo. Antibiotics are primarily recommended to treat severe traveler’s diarrhea. Despite a few side effects, within the drug class segment, antibiotics are likely to stay ahead with a market share of ~51% during the forecast period. The management and treatment of traveler’s diarrhea are expected to evolve, owing to the formulation of different guidelines laid down by regulatory bodies worldwide. As per the new guidelines, the use of antibiotics for mild traveler’s diarrhea is not recommended, as they have been linked to adverse events.
Antidiarrheal agents, such as bismuth subsalicylate and loperamide, are predominantly used in conjunction with antibiotics to offer instant relief from the symptoms of traveler’s diarrhea. The treatment of traveler’s diarrhea primarily depends on the severity of the treatment. Oral rehydration solutions are ideally used to treat traveler’s diarrhea in children, infants, and geriatric population, as these patients are more susceptible to dehydration and electrolyte imbalance. The oral rehydration solution and antidiarrheal segments of the traveler’s diarrhea treatment market are collectively expected to reach a value of ~US$ 511 Mn by the end of 2027.
To understand how our report can bring difference to your business strategy, Ask for a brochure
Traveler’s diarrhea is predominantly caused by pathogens such as viruses, bacteria, and protozoa. Of these, nearly 80% of the cases are caused by bacteria, and thus, this segment is projected to account for ~ 69% share of the traveler’s diarrhea treatment market in 2019. Viruses are the causative agents for ~5-10% cases depending on geographical location. As per the Centers for Disease Control and Prevention data, norovirus and rotavirus are the leading types of viruses that cause traveler’s diarrhea. E.coli and Salmonella Spp are the two major bacteria types responsible for traveler’s diarrhea. According to the British Medical Journal, the prevalence of traveler’s diarrhea is higher among travelers visiting regions in South Asia and Southeast Asia. Thus, the traveler’s diarrhea treatment market is expected to grow during the forecast period.
Stuck in a neck-to-neck competition with other brands? Request a custom report on “Traveler’s Diarrhea Treatment Market”
Analysts’ Viewpoint
The traveler’s diarrhea treatment market is expected to expand at a healthy CAGR of ~7% during the forecast period. Development of new drugs, growing awareness among travelers, and approval from the FDA will continue to play an imperative role in the growth of the traveler’s diarrhea treatment market in the near future. Companies in the traveler’s diarrhea treatment market landscape should focus on the development of new drugs and ensure they are compliant with the current guidelines. Among regions, with a market share of ~42% in 2018, North America will retain its lead during the forecast period, owing to product approvals and early adoption of new products.
Traveler’s Diarrhea Treatment Market: Overview
Surge in Number of Travelers and Awareness Among Travelers: A Key Driver
Development of New Treatments
Trend of Self-medication Using OTC Products and Misuse of Antibiotics Hamper Traveler’s Diarrhea Treatment Market
Traveler’s Diarrhea Treatment Market: Competition Landscape
Global Traveler’s Diarrhea Treatment Market: Key Developments
Key players in the global traveler’s diarrhea treatment market are engaged in the development of new products and approvals, merger & acquisitions, and collaborations. Strategies adopted by key players are likely to boost the global traveler’s diarrhea treatment market. Major strategies adopted by the players in the traveler’s diarrhea treatment market are:
The report on the global traveler’s diarrhea treatment market discusses individual strategies, followed by company profiles of manufacturers of traveler’s diarrhea treatment products. The competitive landscape section is included in the traveler’s diarrhea treatment report to provide readers with a dashboard view and a company market share analysis of key players operating in the global traveler’s diarrhea treatment market.
Traveler’s Diarrhea Treatment Market - Segmentation
|
Drug Class |
|
|
Pathogen |
|
|
Age Group |
|
|
Distribution Channel |
|
|
Region |
|
Traveler’s diarrhea treatment market is expected to reach a value of ~US$ 1.3 Bn by 2027
Traveler’s diarrhea treatment market is projected to expand at a CAGR of ~7% from 2019 to 2027
Traveler’s diarrhea treatment market is driven by surge in the number of travelers and rise in awareness among travelers about traveler’s diarrhea
North america accounted for a major share of the global traveler’s diarrhea treatment market
Key players in the global traveler’s diarrhea treatment market include Johnson & Johnson (Johnson & Johnson Consumer Inc.), Bausch Health Companies Inc. (Salix Pharmaceuticals), COSMO PHARMACEUTICALS, Immuron, Valneva SE
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Traveler’s Diarrhea Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Drug Class Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Surge in Number of Travelers
4.3.1.2. Awareness Among Travelers
4.3.1.3. Evolution of Pathogens and Antimicrobial Resistance
4.3.1.4. Rise in Number of Food Contamination Cases
4.3.1.5. New Therapeutics in Development
4.3.2. Restraints
4.3.2.1. Trend of Self-medication Using OTC Products and Misuse of Antibiotics
4.3.2.2. Awareness about Hygiene
4.3.2.3. Introduction of Generic Products
4.3.3. Opportunities
4.4. Global Traveler’s Diarrhea Treatment Market Analysis and Forecasts, 2017–2027
5. Market Outlook
5.1. Overview of Guidelines for Diagnosis & Treatment of Traveler’s Diarrhea
5.2. Private/Public Sector Drug Supply Chain by Region/Country
5.3. Pipeline Analysis
5.4. Epidemiology of Traveler’s Diarrhea by Region/Sub-region
5.5. Overview of Causes/Percentage of Bacteria, Viruses and Protozoa Causing Traveler’s Diarrhea
6. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, by Drug Class
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Traveler’s Diarrhea Treatment Market Value Forecast, by Drug Class, 2017–2027
6.3.1. Oral Rehydration Therapy (ORS)
6.3.2. Antidiarrheal Agents
6.3.2.1. Antibiotics
6.3.2.2. Azithromycin
6.3.2.3. Ciprofloxacin
6.3.2.4. Quinolones
6.3.2.5. Rifaximin
6.3.3. Vaccines/prophylactics
6.3.4. Others
6.4. Global Traveler’s Diarrhea Treatment Market Attractiveness, by Drug Class
7. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, by Pathogen
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Traveler’s Diarrhea Treatment Market Value Forecast, by Pathogen, 2017–2027
7.3.1. Bacteria
7.3.1.1. E. Coli
7.3.1.2. Salmonella Spp
7.3.1.3. Others
7.3.2. Viruses
7.3.3. Protozoa
7.3.3.1. Giardiasis
7.3.3.2. Cryptosporidium parvum
7.4. Global Traveler’s Diarrhea Treatment Market Attractiveness, by Pathogen
8. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, by Age
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Traveler’s Diarrhea Treatment Market Value Forecast, by Age, 2017–2027
8.3.1. Adults
8.3.2. Children
8.4. Global Traveler’s Diarrhea Treatment Market Attractiveness, by Age
9. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, by Distribution Channel
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Global Traveler’s Diarrhea Treatment Market Value Forecast, by Distribution Channel, 2017–2027
9.3.1. Retail Pharmacies
9.3.2. Hospital Pharmacies
9.3.3. Online Pharmacies
9.4. Global Traveler’s Diarrhea Treatment Market Attractiveness, by Distribution Channel
10. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Traveler’s Diarrhea Treatment Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global Traveler’s Diarrhea Treatment Market Attractiveness, by Region
11. North America Traveler’s Diarrhea Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. North America Traveler’s Diarrhea Treatment Market Value Forecast, by Drug Class , 2017–2027
11.2.1. Oral Rehydration Therapy (ORS)
11.2.2. Antidiarrheal Agents
11.2.3. Antibiotics
11.2.3.1. Azithromycin
11.2.3.2. Ciprofloxacin
11.2.3.3. Quinolones
11.2.3.4. Rifaximin
11.2.4. Vaccines/prophylactics
11.2.5. Others
11.3. North America Traveler’s Diarrhea Treatment Market Value Forecast, by Pathogen, 2017–2027
11.3.1. Bacteria
11.3.1.1. E. Coli
11.3.1.2. Salmonella Spp
11.3.1.3. Others
11.3.2. Viruses
11.3.3. Protozoa
11.3.3.1. Giardiasis
11.3.3.2. Cryptosporidium parvum
11.4. North America Traveler’s Diarrhea Treatment Market Value Forecast, by Age, 2017–2027
11.4.1. Adults
11.4.2. Children
11.5. North America Traveler’s Diarrhea Treatment Market Value Forecast, by Distribution Channel, 2017–2027
11.5.1. Retail Pharmacies
11.5.2. Hospital Pharmacies
11.5.3. Online Pharmacies
11.6. North America Traveler’s Diarrhea Treatment Market Value Forecast, by Country, 2017–2027
11.6.1. U.S.
11.6.2. Canada
11.7. North America Traveler’s Diarrhea Treatment Market Attractiveness Analysis
11.7.1. By Drug Class
11.7.2. By Pathogen
11.7.3. By Age
11.7.4. By Distribution Channel
11.7.5. By Country
12. Europe Traveler’s Diarrhea Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Europe Traveler’s Diarrhea Treatment Market Value Forecast, by Drug Class , 2017–2027
12.2.1. Oral Rehydration Therapy (ORS)
12.2.2. Antidiarrheal Agents
12.2.3. Antibiotics
12.2.3.1. Azithromycin
12.2.3.2. Ciprofloxacin
12.2.3.3. Quinolones
12.2.3.4. Rifaximin
12.2.4. Vaccines/prophylactics
12.2.5. Others
12.3. Europe Traveler’s Diarrhea Treatment Market Value Forecast, by Pathogen, 2017–2027
12.3.1. Bacteria
12.3.1.1. E. Coli
12.3.1.2. Salmonella Spp
12.3.1.3. Others
12.3.2. Viruses
12.3.3. Protozoa
12.3.3.1. Giardiasis
12.3.3.2. Cryptosporidium parvum
12.4. Europe Traveler’s Diarrhea Treatment Market Value Forecast, by Age, 2017–2027
12.4.1. Adults
12.4.2. Children
12.5. Europe Traveler’s Diarrhea Treatment Market Value Forecast, by Distribution Channel, 2017–2027
12.5.1. Retail Pharmacies
12.5.2. Hospital Pharmacies
12.5.3. Online Pharmacies
12.6. Europe Traveler’s Diarrhea Treatment Market Value Forecast, by Country/Sub-region, 2017–2027
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe Traveler’s Diarrhea Treatment Market Attractiveness Analysis
12.7.1. By Drug Class
12.7.2. By Pathogen
12.7.3. By Age
12.7.4. By Distribution Channel
12.7.5. By Country/Sub-region
13. Asia Pacific Traveler’s Diarrhea Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Asia Pacific Traveler’s Diarrhea Treatment Market Value Forecast, by Drug Class, 2017–2027
13.2.1. Oral Rehydration Therapy (ORS)
13.2.2. Antidiarrheal Agents
13.2.3. Antibiotics
13.2.3.1. Azithromycin
13.2.3.2. Ciprofloxacin
13.2.3.3. Quinolones
13.2.3.4. Rifaximin
13.2.4. Vaccines/prophylactics
13.2.5. Others
13.3. Asia Pacific Traveler’s Diarrhea Treatment Market Value Forecast, by Pathogen, 2017–2027
13.3.1. Bacteria
13.3.1.1. E. Coli
13.3.1.2. Salmonella Spp
13.3.1.3. Others
13.3.2. Viruses
13.3.3. Protozoa
13.3.3.1. Giardiasis
13.3.3.2. Cryptosporidium parvum
13.4. Asia Pacific Traveler’s Diarrhea Treatment Market Value Forecast, by Age, 2017–2027
13.4.1. Adults
13.4.2. Children
13.5. Asia Pacific Traveler’s Diarrhea Treatment Market Value Forecast, by Distribution Channel, 2017–2027
13.5.1. Retail Pharmacies
13.5.2. Hospital Pharmacies
13.5.3. Online Pharmacies
13.6. Asia Pacific Traveler’s Diarrhea Treatment Market Value Forecast, by Country/Sub-region, 2017–2027
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Asia Pacific Traveler’s Diarrhea Treatment Market Attractiveness Analysis
13.7.1. By Drug Class
13.7.2. By Pathogen
13.7.3. By Age
13.7.4. By Distribution Channel
13.7.5. By Country/Sub-region
14. Latin America Traveler’s Diarrhea Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Latin America Traveler’s Diarrhea Market Value Forecast, by Drug Class , 2017–2027
14.2.1. Oral Rehydration Therapy (ORS)
14.2.2. Antidiarrheal Agents
14.2.3. Antibiotics
14.2.3.1. Azithromycin
14.2.3.2. Ciprofloxacin
14.2.3.3. Quinolones
14.2.3.4. Rifaximin
14.2.4. Vaccines/prophylactics
14.2.5. Others
14.3. Latin America Traveler’s Diarrhea Market Value Forecast, by Pathogen, 2017–2027
14.3.1. Bacteria
14.3.1.1. E. Coli
14.3.1.2. Salmonella Spp
14.3.1.3. Others
14.3.2. Viruses
14.3.3. Protozoa
14.3.3.1. Giardiasis
14.3.3.2. Cryptosporidium parvum
14.4. Latin America Traveler’s Diarrhea Market Value Forecast, by Age, 2017–2027
14.4.1. Adults
14.4.2. Children
14.5. Latin America Traveler’s Diarrhea Market Value Forecast, by Distribution Channel, 2017–2027
14.5.1. Retail Pharmacies
14.5.2. Hospital Pharmacies
14.5.3. Online Pharmacies
14.6. Latin America Traveler’s Diarrhea Market Value Forecast, by Country/Sub-region, 2017–2027
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America Traveler’s Diarrhea Market Attractiveness Analysis
14.7.1. By Drug Class
14.7.2. By Pathogen
14.7.3. By Age
14.7.4. By Distribution Channel
14.7.5. By Country/Sub-region
15. Middle East & Africa Traveler’s Diarrhea Treatment Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Middle East & Africa Traveler’s Diarrhea Treatment Market Value Forecast, by Drug Class , 2017–2027
15.2.1. Oral Rehydration Therapy (ORS)
15.2.2. Antidiarrheal Agents
15.2.3. Antibiotics
15.2.3.1. Azithromycin
15.2.3.2. Ciprofloxacin
15.2.3.3. Quinolones
15.2.3.4. Rifaximin
15.2.4. Vaccines/prophylactics
15.2.5. Others
15.3. Middle East & Africa Traveler’s Diarrhea Treatment Market Value Forecast, by Pathogen, 2017–2027
15.3.1. Bacteria
15.3.1.1. E. Coli
15.3.1.2. Salmonella Spp
15.3.1.3. Others
15.3.2. Viruses
15.3.3. Protozoa
15.3.3.1. Giardiasis
15.3.3.2. Cryptosporidium parvum
15.4. Middle East & Africa Traveler’s Diarrhea Treatment Market Value Forecast, by Age, 2017–2027
15.4.1. Adults
15.4.2. Children
15.5. Middle East & Africa Traveler’s Diarrhea Treatment Market Value Forecast, by Distribution Channel, 2017–2027
15.5.1. Retail Pharmacies
15.5.2. Hospital Pharmacies
15.5.3. Online Pharmacies
15.6. Middle East & Africa Traveler’s Diarrhea Treatment Market Value Forecast, by Country/Sub-region, 2017–2027
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Middle East & Africa Traveler’s Diarrhea Treatment Market Attractiveness Analysis
15.7.1. By Drug Class
15.7.2. By Pathogen
15.7.3. By Age
15.7.4. By Distribution Channel
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of companies)
16.2. Market Share Analysis/Ranking By Company (2018)
16.3. Company Profiles
16.3.1. Johnson & Johnson (Johnson & Johnson Consumer Inc.)
16.3.1.1. Company Overview
16.3.1.2. Company Financials
16.3.1.3. Growth Strategies
16.3.1.4. SWOT Analysis
16.3.2. Bausch Health Companies Inc. (Salix Pharmaceuticals)
16.3.2.1. Company Overview
16.3.2.2. Company Financials
16.3.2.3. Growth Strategies
16.3.2.4. SWOT Analysis
16.3.3. COSMO PHARMACEUTICALS
16.3.3.1. Company Overview
16.3.3.2. Company Financials
16.3.3.3. Growth Strategies
16.3.3.4. SWOT Analysis
16.3.4. Immuron
16.3.4.1. Company Overview
16.3.4.2. Company Financials
16.3.4.3. Growth Strategies
16.3.4.4. SWOT Analysis
16.3.5. Valneva SE
16.3.5.1. Company Overview
16.3.5.2. Company Financials
16.3.5.3. Growth Strategies
16.3.5.4. SWOT Analysis
16.3.6. Sun Pharmaceutical Industries Ltd.
16.3.6.1. Company Overview
16.3.6.2. Company Financials
16.3.6.3. Growth Strategies
16.3.6.4. SWOT Analysis
16.3.7. Norgine
16.3.7.1. Company Overview
16.3.7.2. Company Financials
16.3.7.3. Growth Strategies
16.3.7.4. SWOT Analysis
16.3.8. Perrigo Company plc
16.3.8.1. Company Overview
16.3.8.2. Company Financials
16.3.8.3. Growth Strategies
16.3.8.4. SWOT Analysis
16.3.9. Bayer AG
16.3.9.1. Company Overview
16.3.9.2. Company Financials
16.3.9.3. SWOT Analysis
List of Tables
Table 01: Global Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027
Table 02: Global Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Antibiotics, 2017–2027
Table 03: Global Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Pathogen, 2017–2027
Table 04: Global Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Bacteria, 2017–2027
Table 05: Global Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Protozoa, 2017–2027
Table 06: Global Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Age, 2017–2027
Table 07: Global Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 08: Global Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 09: North America Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027
Table 10: North America Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Antibiotics, 2017–2027
Table 11: North America Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Pathogen, 2017–2027
Table 12: North America Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Bacteria 2017–2027
Table 13: North America Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Protozoa 2017–2027
Table 14: North America Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Age 2017–2027
Table 15: North America Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 16: North America Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 17: Europe Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027
Table 18: Europe Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Antibiotics, 2017–2027
Table 19: Europe Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Pathogen, 2017–2027
Table 20: Europe Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Bacteria 2017–2027
Table 21: Europe Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Protozoa 2017–2027
Table 22: Europe Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Age 2017–2027
Table 23: Europe Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 24: Europe Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 25: Asia Pacific Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027
Table 26: Asia Pacific Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Antibiotics, 2017–2027
Table 27: Asia Pacific Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Pathogen, 2017–2027
Table 28: Asia Pacific Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Bacteria 2017–2027
Table 29: Asia Pacific Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Protozoa 2017–2027
Table 30: Asia Pacific Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Age 2017–2027
Table 31: Asia Pacific Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 32: Asia Pacific Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 33: Latin America Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027
Table 34: Latin America Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Antibiotics, 2017–2027
Table 35: Latin America Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Pathogen, 2017–2027
Table 36: Latin America Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Bacteria 2017–2027
Table 37: Latin America Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Protozoa 2017–2027
Table 38: Latin America Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Age 2017–2027
Table 39: Latin America Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 40: Latin America Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 41: Middle East & Africa Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027
Table 42: Middle East & Africa Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Antibiotics, 2017–2027
Table 43: Middle East & Africa Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Pathogen, 2017–2027
Table 44: Middle East & Africa Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Bacteria 2017–2027
Table 45: Middle East & Africa Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Protozoa 2017–2027
Table 46: Middle East & Africa Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Age 2017–2027
Table 47: Middle East & Africa Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 48: Middle East & Africa Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
List of Figures
Figure 01: Global Traveler’s Diarrhea Treatment Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027
Figure 02: Global Traveler’s Diarrhea Treatment Market Value (US$ Mn), by Drug Class, 2018
Figure 03: Global Traveler’s Diarrhea Treatment Market Value Share Analysis by Pathogen, 2018
Figure 04: Market Overview
Figure 05: Global Traveler’s Diarrhea Treatment Market Value Share, by Drug Class, 2018
Figure 06: Global Traveler’s Diarrhea Treatment Market Value Share, by Pathogen, 2018
Figure 07: Global Traveler’s Diarrhea Treatment Market Value Share, by Age, 2018
Figure 08: Global Traveler’s Diarrhea Treatment Market Value Share, by Distribution Channel, 2018
Figure 09: Global Traveler’s Diarrhea Treatment Market Value Share, by Region, 2018
Figure 10: Global Traveler’s Diarrhea Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 11: Global Traveler's Diarrhea Treatment Market Value Share Analysis, by Drug Class, 2018 and 2027
Figure 12: Global Traveler's Diarrhea Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Oral Rehydration Therapy (ORS), 2017–2027
Figure 13: Global Traveler's Diarrhea Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Antidiarrheal Agents, 2017–2027
Figure 14: Global Traveler's Diarrhea Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Antibiotics, 2017–2027
Figure 15: Global Traveler's Diarrhea Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Vaccines/prophylactics, 2017–2027
Figure 16: Global Traveler's Diarrhea Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2017–2027
Figure 17: Global Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Drug Class, 2019–2027
Figure 18: Global Traveler's Diarrhea Treatment Market Value Share Analysis, by Pathogen, 2018 and 2027
Figure 19: Global Traveler's Diarrhea Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Bacteria, 2017–2027
Figure 20: Global Traveler's Diarrhea Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Viruses, 2017–2027
Figure 21: Global Traveler's Diarrhea Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Protozoa, 2017–2027
Figure 22: Global Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Pathogen, 2019–2027
Figure 23: Global Traveler's Diarrhea Treatment Market Value Share Analysis, by Age, 2018 and 2027
Figure 24: Global Traveler's Diarrhea Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Adults, 2017–2027
Figure 25: Global Traveler's Diarrhea Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Children, 2017–2027
Figure 26: Global Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Age, 2019–2027
Figure 27: Global Traveler's Diarrhea Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 28: Global Traveler's Diarrhea Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Retail Pharmacies, 2017–2027
Figure 29: Global Traveler's Diarrhea Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Hospital Pharmacies, 2017–2027
Figure 30: Global Traveler's Diarrhea Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Online Pharmacies, 2017–2027
Figure 31: Global Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Distribution Channel, 2019–2027
Figure 32: Global Traveler's Diarrhea Treatment Market Value Share Analysis, by Region, 2018 and 2027
Figure 33: Global Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Region, 2019–2027
Figure 34: North America Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 35: North America Traveler's Diarrhea Treatment Market Value Share Analysis, by Drug Class, 2018 and 2027
Figure 36: North America Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Drug Class, 2019–2027
Figure 37: North America Traveler's Diarrhea Treatment Market Value Share Analysis, by Pathogen, 2018 and 2027
Figure 38: North America Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Pathogen, 2019–2027
Figure 39: North America Traveler's Diarrhea Treatment Market Value Share Analysis, by Age, 2018 and 2027
Figure 40: North America Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Age, 2019–2027
Figure 42: North America Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Distribution Channel, 2019 -2027
Figure 41: North America Traveler's Diarrhea Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 44: North America Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Country, 2019–2027
Figure 43: North America Traveler's Diarrhea Treatment Market Value Share Analysis, by Country, 2018 and 2027
Figure 45: Europe Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 46: Europe Traveler's Diarrhea Treatment Market Value Share Analysis, by Drug Class, 2018 and 2027
Figure 47: Europe Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Drug Class, 2019–2027
Figure 48: Europe Traveler's Diarrhea Treatment Market Value Share Analysis, by Pathogen, 2018 and 2027
Figure 49: Europe Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Pathogen, 2019–2027
Figure 50: Europe Traveler's Diarrhea Treatment Market Value Share Analysis, by Age, 2018 and 2027
Figure 51: Europe Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Age, 2019–2027
Figure 52: Europe Traveler's Diarrhea Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 53: Europe Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Distribution Channel, 2019 -2027
Figure 54: Europe Traveler's Diarrhea Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 55: Europe Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 56: Asia Pacific Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 57: Asia Pacific Traveler's Diarrhea Treatment Market Value Share Analysis, by Drug Class, 2018 and 2027
Figure 58: Asia Pacific Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Drug Class, 2019–2027
Figure 59: Asia Pacific Traveler's Diarrhea Treatment Market Value Share Analysis, by Pathogen, 2018 and 2027
Figure 60: Asia Pacific Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Pathogen, 2019–2027
Figure 61: Asia Pacific Traveler's Diarrhea Treatment Market Value Share Analysis, by Age, 2018 and 2027
Figure 62: Asia Pacific Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Age, 2019–2027
Figure 63: Asia Pacific Traveler's Diarrhea Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 64: Asia Pacific Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Distribution Channel, 2019 -2027
Figure 65: Asia Pacific Traveler's Diarrhea Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 66: Asia Pacific Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 67: Latin America Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 68: Latin America Traveler's Diarrhea Treatment Market Value Share Analysis, by Drug Class, 2018 and 2027
Figure 69: Latin America Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Drug Class, 2019–2027
Figure 70: Latin America Traveler's Diarrhea Treatment Market Value Share Analysis, by Pathogen, 2018 and 2027
Figure 71: Latin America Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Pathogen, 2019–2027
Figure 72: Latin America Traveler's Diarrhea Treatment Market Value Share Analysis, by Age, 2018 and 2027
Figure 73: Latin America Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Age, 2019–2027
Figure 74: Latin America Traveler's Diarrhea Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 75: Latin America Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Distribution Channel, 2019 -2027
Figure 76: Latin America Traveler's Diarrhea Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 77: Latin America Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 78: Middle East & Africa Traveler's Diarrhea Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 79: Middle East & Africa Traveler's Diarrhea Treatment Market Value Share Analysis, by Drug Class, 2018 and 2027
Figure 80: Middle East & Africa Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Drug Class, 2019–2027
Figure 81: Middle East & Africa Traveler's Diarrhea Treatment Market Value Share Analysis, by Pathogen, 2018 and 2027
Figure 82: Middle East & Africa Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Pathogen, 2019–2027
Figure 83: Middle East & Africa Traveler's Diarrhea Treatment Market Value Share Analysis, by Age, 2018 and 2027
Figure 84: Middle East & Africa Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Age, 2019–2027
Figure 85: Middle East & Africa Traveler's Diarrhea Treatment Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 86: Middle East & Africa Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Distribution Channel, 2019 -2027
Figure 87: Middle East & Africa Traveler's Diarrhea Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 88: Middle East & Africa Traveler's Diarrhea Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Traveler’s Diarrhea Treatment Market
*86 figures and 60 tables includes